MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹10,260 Cr | ₹874,943 Cr | ₹7,782 Cr | ₹621 Cr | ₹58,719 Cr |
What is the latest Revenue of MANKIND PHARMA ?
Year | Revenue |
---|---|
Mar2025 | ₹10,260 Cr |
Mar2024 | ₹874,943 Cr |
Mar2023 | ₹7,782 Cr |
Mar2022 | ₹621 Cr |
Mar2021 | ₹58,719 Cr |
How is Revenue of MANKIND PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹10,260 Cr | -98.83 | |
Mar2024 | ₹874,943 Cr | 11,143.81 | |
Mar2023 | ₹7,782 Cr | 1,152.18 | |
Mar2022 | ₹621 Cr | -98.94 | |
Mar2021 | ₹58,719 Cr | - |
Compare Revenue of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹106,270.3 Cr | -0.5% | 12.5% | 23.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -0.5% |
12.5% |
23.8% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses